Stay updated on Rebastinib with Paclitaxel in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Rebastinib with Paclitaxel in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rebastinib with Paclitaxel in Solid Tumors Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Revision: v3.5.2 has been added and Revision: v3.5.0 has been removed.
    Difference
    0.0%
    Check dated 2026-04-16T11:10:46.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The page's revision badge was updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-18T18:04:56.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    Revision label updated to v3.4.3 in the page footer, replacing the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T14:40:54.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and Revision: v3.4.1 removed, reflecting a maintenance update on the site. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T09:27:17.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    A general site notice about a lapse in government funding and NIH operating status was added, directing users to cc.nih.gov and opm.gov for updates. The site revision version was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T06:23:13.000Z thumbnail image
  9. Check
    78 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and new metadata items 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. Removed the previous metadata items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-28T04:07:40.000Z thumbnail image

Stay in the know with updates to Rebastinib with Paclitaxel in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rebastinib with Paclitaxel in Solid Tumors Clinical Trial page.